InspireMD (NSPR) Return on Capital Employed Growth (1y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | 19.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.00 |
| Sep 30, 2025 | 2,079.00 |
| Jun 30, 2025 | 717.00 |
| Mar 31, 2025 | 3,010.00 |
| Dec 31, 2024 | 3,301.00 |
| Sep 30, 2024 | -2,237.00 |
| Jun 30, 2024 | -454.00 |
| Mar 31, 2024 | 4,343.00 |
| Dec 31, 2023 | 3,852.00 |
| Sep 30, 2023 | 2,394.00 |
| Jun 30, 2023 | -168.00 |
| Mar 31, 2023 | -5,686.00 |
| Dec 31, 2022 | -4,793.00 |
| Sep 30, 2022 | -3,137.00 |
| Jun 30, 2022 | -2,964.00 |
| Mar 31, 2022 | -860.00 |
| Dec 31, 2021 | 3,994.00 |
| Sep 30, 2021 | 2,942.00 |
| Jun 30, 2021 | 6,741.00 |
| Mar 31, 2021 | 10,593.00 |
| Dec 31, 2020 | 4,863.00 |
| Sep 30, 2020 | 5,205.00 |
| Jun 30, 2020 | 2,663.00 |
| Mar 31, 2020 | -4,145.00 |
| Dec 31, 2019 | -5,386.00 |
| Sep 30, 2019 | -4,358.00 |
| Jun 30, 2019 | -494.00 |
| Mar 31, 2019 | 10,503.00 |
| Dec 31, 2018 | 12,473.00 |
| Sep 30, 2018 | 9,443.00 |
| Jun 30, 2018 | 214.00 |
| Mar 31, 2018 | -10,385.00 |
| Dec 31, 2017 | -7,517.00 |
| Sep 30, 2017 | 21,842.00 |
| Mar 31, 2014 | -806,386.00 |
| Sep 30, 2013 | 4,334.00 |
| Mar 31, 2013 | 820,309.00 |
| Dec 31, 2012 | -44,300.00 |
| Sep 30, 2012 | -6,450.00 |